OOIR: Observatory of International Research

Papers

(The H4-Index of Thorax is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Beware, vaping e-cigarettes around children is adversely impacting their lung health	155
Ablation for lung cancer: hot or cold intervention	103
Vaping and CBD: can new technology overcome old problems?	101
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges	95
Journal club	82
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically	82
Correction:British Thoracic Society Winter Meeting 2023	77
E-cigarette use in young adults and adolescents: not so safe?	75
Fibrosing mediastinitis: ‘haemoptysis in the Heartland’	74
Strengthening the evidence base to support stronger regulation of social media based advertising of e-cigarette products to youth	58
Ultrafine particles and health: the next frontier in understanding air pollution hazards	57
Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline	57
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma	56
British Thoracic Society Guideline for pleural disease	56
Lung development genes, adult lung function and cardiovascular comorbidities	54
Complex coexistence of COPD and cardiovascular disease	52
TB PCR in BAL and EBUS-TBNA samples for the diagnosis of pulmonary and mediastinal lymph node TB: retrospective TRiBE study	51
Is the provision of a national opt-out tobacco dependence treatment service in acute hospitals in England equitable? A national cohort study	50
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial	49
Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007–2018	47
Highlights from this issue	46
Correction:RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock	46
Toxic metals and lung health: silent poisons?	46
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data	46
Muscle memory: genetic factors underlying functional impairment in COPD	45

Implications of the 2022 lung function update and GLI global reference equations among patients with interstitial lung disease	44
Delayed presentation of pulmonary Echinococcus in a patient with no major risk factors	44
Differentiation of malignant from benign pleural effusions based on artificial intelligence	44
Lower airway microbiota in COPD and healthy controls	43
Ageing and ivacaftor: unravelling the long-term effects	43
Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020	43
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care	42
Intensive care unit interventions to promote sleep and circadian biology in reducing incident delirium: a scoping review	42
Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study	42
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy	39
BTS Clinical Statement on air travel for passengers with respiratory disease	38
COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes—a systematic review and meta-analysis	38
Short-term exposure to ultrafine particles and asthma hospital admissions in children in Copenhagen, Denmark	37